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Background: Computer-aided lung sound analysis (LSA) has been reported to be useful for evaluating
airway inﬂammation and obstruction in asthma patients. We investigated the relation between LSA and
impulse oscillometry with the evaluation of peripheral airway obstruction.
Methods: A total of 49 inhaled corticosteroid-naive bronchial asthma patients underwent LSA, spirom-
etry, impulse oscillometry, and airway hyperresponsiveness testing. The data were analyzed to assess
correlations between the expiration: inspiration lung sound power ratio (dB) at low frequencies between
100 and 195 Hz (E/I LF) and various parameters.
Results: E/I LF and X5 were identiﬁed as independent factors that affect _V50;%predicted. E/I LF showed a
positive correlation with R5 (r ¼ 0.34, p ¼ 0.017), R20 (r ¼ 0.34, p ¼ 0.018), reactance area (AX, r ¼ 0.40,
p ¼ 0.005), and resonant frequency of reactance (Fres, r ¼ 0.32, p ¼ 0.024). A negative correlation was
found between E/I LF and X5 (r ¼ 0.47, p ¼ 0.0006). E/I LF showed a negative correlation with FEV1/
FVC(%), FEV1,%predicted, _V50;%predicted, and _V25;%predicted (r ¼ 0.41, p ¼ 0.003; r ¼ 0.44, p ¼ 0.002;
r ¼ 0.49, p ¼ 0.0004; and r ¼ 0.30, p ¼ 0.024, respectively). E/I LF was negatively correlated with
log PC20 (r ¼ 0.30, p ¼ 0.024). Log PC20, X5, and past smoking were identiﬁed as independent factors
that affected E/I LF level.
Conclusions: E/I LF as with X5 can be an indicator of central and peripheral airway obstruction in
bronchial asthma patients.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In asthma patients, lung sounds have typically been used to
assess the degree of airway narrowing, where rhonchi and wheezes
are important adventitious sounds.1e3 However, it is often difﬁcult
to distinguish slight abnormalities in lung sounds in asthmatic
patients when they are not having exacerbations and when no
rhonchi or wheezes are audible. Several studies have attempted to
overcome such difﬁculties by utilizing computer-aided lung sound
analysis (LSA).4,5 In auscultation, vesicular breath sounds generally
originate from areas far from the large airways, such as the base ofFukuoka National Hospital,
pan.
(T. Shimoda).
ety of Allergology.
rgology. Production and hosting by Elsethe lungs. Vesicular breath sounds are primarily inspiratory sounds
that have a soft quality. In contrast, bronchial breath sounds have a
harsher quality in areas closer to the large airways. Whenwe listen
to bronchial breath sounds in the peripheral lung area, they are
abnormal and suggest stiff lungs or narrowing airways.6 We pre-
viously reported that the expiration-to-inspiration sound power
ratio in a low-frequency range, between 100 and 195 Hz (E/I LF),
increased in bronchial asthma patients with airway inﬂammation
and obstruction.7
Recently, impulse oscillometry (IOS) has been increasingly used
as a noninvasive method to assess airway resistance and reac-
tance.8,9 IOS is effort independent and quantiﬁes the obstruction
degrees in the central and peripheral airways.10 Though the eval-
uation of IOS is still controversial, the reactance at 5 Hz (X5) is
suggested as an index of the peripheral airway obstruction.9
We performed analyses to assess correlations between E/I LF or
ﬂow-volume curves, especially with _V50 as peripheral airwayvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
T. Shimoda et al. / Allergology International 66 (2017) 132e138 133obstruction index, and assessed whether E/I LF can be used to
evaluate airway obstruction. We also investigated potential factors
affecting E/I LF levels.Methods
Subjects
The analysis set consisted of 49 mild and moderate persistent
bronchial asthma patients who visited our department since
January 1st, 2012 to December 31st, 2014. Bronchial asthma was
diagnosed according to the Global Initiative for Asthma Guide-
lines.11 All subjects had positive airway hyperresponsiveness to
inhaled acetylcholine and needed to have a history of wheezing
and/or dyspnea. At the initial visit, 80% of the subjects showed
positive reversibility (reversible with at least 12% and 200 ml im-
provements in FEV1 after bronchodilator therapy), whereas the
remaining 20% exhibited negative reversibility with normal respi-
ratory function at the visit and were diagnosed with bronchial
asthma based on airway hyperresponsiveness and medical history.Fig. 1. Sound spectrogram display of lung sounds in a patient. Upper ﬁgure. The recorded
spectrograph with the frequencies in Hz on the vertical axis and time on the horizontal ax
selected portion of the range of an inspiratory or expiratory position. We calculated the avAt the time of enrollment, the study patients were not receiving
treatment with inhaled or systemic corticosteroids. The use of anti-
asthma drugs, including bronchodilators, was discontinued for at
least 24 h prior to the examination. Subjects with a history of
chronic obstructive pulmonary disease (COPD) or any cardiovas-
cular diseases, as well as those with a current viral or bacterial
infection, were excluded from the study. The healthy volunteer
subjects (n ¼ 32) had no respiratory symptoms, had no overt ill-
nesses, and exhibited no abnormalities in their lung function tests
and chest radiographies. The ethics committee of Fukuoka National
Hospital approved the study protocol (protocol No. 20-12), and all
participants received verbal and written information about the
study before providing their informed consent.Measurement of LSA
Lung sounds were recorded for 30 s over the base of the left
lung using a hand-held microphone according to the procedure
described in a previous study.7 The sound recording was performed
in a quiet room, but not in a soundproof booth, in the outpatientsounds were analyzed using fast Fourier analysis, and the results are displayed as a
is. The sound intensity (dBm) is illustrated with color and brightness. Lower ﬁgure. A
erage power (dB) of low frequencies from 100 to 195 Hz.
Table 1
Demographic and clinical characteristics of the subjects.
Bronchial asthma (n ¼ 49) Healthy volunteers (n ¼ 32)
Mean ± SD
(minimumemaximum)
Mean ± SD
(minimumemaximum)
Age (year) 43 ± 13 (20e65) 41 ± 14 (21e66)
BMI 22.2 ± 2.9 (16.6e30.5) 22.6 ± 3.9 (17.0e22.9)
Male/female 11/38 13/19
Duration (year) 6.1 ± 9.6 e
Smoking
Non/experience/
current
24/13/12 16/7/9
Atopic/non-atopic 20/28 e
FEV1/FVC (%) 77.9 ± 9.1 84.2 ± 6.8***
FEV1,%predicted (%) 95.5 ± 16.6 102.0 ± 11.4*
_V50;%predicted (%) 71.3 ± 27.1 90.1 ± 18.5***
_V25;%predicted (%) 53.6 ± 27.0 79.5 ± 23.7***
IgE (IU/ml) 258 ± 312 e
PC20 1484 ± 1471 e
*p < 0.05, ***p < 0.001.
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mouthpiece to synchronize their breath cycles while the breath
sounds were recorded. The recording system consisted of an
electro-stethoscope containing a wide-range audio sensor attached
to the inside of a diaphragm (Bio-Sound Sensor BSS-01; Kenz
Medico, Saitama, Japan), a signal processing system, and a personal
computer. The sensor had a band-pass ﬁlter range of 40e2500 Hz
and good sound-collecting ability for the 40e2000 Hz range. The
recorded sound was analyzed using a sound spectrometer (LSA-
2008; Kenz Medico, Saitama, Japan).
The recorded sound was analyzed by fast Fourier analysis and
displayed as a spectrograph, with the frequency in Hz on the ver-
tical axis and time on the horizontal axis. The sound intensity
(dBm) is shown as color and brightness (Fig. 1); dBm was used to
express the power of the sound in this study and is an abbreviation
for the power ratio in decibels (dB) of the measured power refer-
enced to 0.001 volts (V).7 We described the low-frequency
(100e195 Hz) expiration: inspiration ratio at the sound pressure
value with E/I LF.7
Measurement of ﬂow-volume curves
Forced vital capacity (FVC), forced expiratory volume in 1 s
(FEV1), and maximal expiratory ﬂow at 50% and 25% ( _V50 and _V25)
were measured with a spirometer (Chest graph HI-701, Chest M.I.,
Tokyo, Japan). The results are expressed as a percentage of pre-
dicted values based on relevant reference standards.11
Measurement of IOS
The MasterScreen device (Erich Jaeger Co., Wurtzburg, Ger-
many) consists of a loudspeaker used as a pulse generator to send
the pressure impulses to the respiratory system. The system was
calibrated through a single volume of air (3 L) at different ﬂow rates
and with a reference resistance device (0.2 kPa/(L/s)). The patients
used nose clips and a disposable mouthpiece (Fit mouthpiece,
Chest, Japan), and they supported their cheeks with their hands to
decrease the shunt compliance. In this study, mean respiratory
resistance values were calculated over a measurement period of
30 s in the frequency range of 5e35 Hz. The impedance (Z) repre-
sents a complex airway resistance, which includes two compo-
nents, namely, the real resistance (R) and the imaginary reactance
(X), which were also determined.8,12
Measurement of airway hyperresponsiveness
Airway hyperresponsivenesswas tested by the standardmethod
using acetylcholine, according to the procedure described in a
previous study.7,13e15 Brieﬂy, the patient ﬁrst inhaled a control of
physiological saline through a nebulizer (PARI BOY 038, PARI
GmbH, Germany). The operating airﬂow rate was 5 L/min. They
then inhaled increasing concentrations of diluted acetylcholine
solutions, from 0.039 to 20 mg/mL, in 2-fold increments. The FEV1
wasmeasured after every 2min of inhalation, and the acetylcholine
concentration at which the FEV1 decreased by 20% was recorded as
PC20, which was used as a marker of airway hyperresponsiveness.
Subjects with a PC20 of less than 8000 mcg/ml were considered to
have airway hyperresponsiveness.
Statistical analysis
By using a boxplot, we examined potential differences in E/I/LF
values between the three groups: “healthy volunteers”, “positive
airway obstruction”, and “negative airway obstruction”. To test the
signiﬁcance of the difference between the pairs of groups, we usedthe SteeleDwass test. The correlation between E/I LF and each
parameter tested was analyzed by Pearson's correlation test. These
data analyses were performed with StatMate IV (ATMS, Tokyo,
Japan). Ordinary least squares procedureswere used in themultiple
regression analysis. A receiver operating characteristic (ROC)
analysis was performed for E/I LF by deﬁning subjects with airway
narrowing as positive. The regression and ROC analyses were per-
formedwith JMP (SAS Institute, Cary, North Carolina, USA). P values
below 0.05 were regarded as statistically signiﬁcant.
Results
Demographic and clinical characteristics of the subjects
The demographic and clinical characteristics of the asthmatic
patients and healthy volunteers are summarized in Table 1. The
ﬂow-volumemeasurements were signiﬁcantly lower in the asthma
patients, but the BMI, age, M/F ratio, and Smoking status were not
different.
Comparison of E/I LF values between bronchial asthma patients and
healthy volunteers
The E/I LF levels in asthma patients with FEV1,%predicted  80%
were not signiﬁcantly different from those in healthy volunteers.
However, patients with FEV1,%predicted < 80% showed signiﬁcantly
higher E/I LF levels than healthy volunteers and patients with FEV1,%
predicted  80% (p ¼ 0.01 and p ¼ 0.04, respectively, Fig. 2a). Simi-
larly, no signiﬁcant difference was observed in E/I LF levels between
healthy volunteers and asthma patients with IOS X5 >0.15 kPa/(L/
s). However, patients with X5  0.15 kPa/(L/s) showed signiﬁ-
cantly higher E/I LF levels than both healthy volunteers and pa-
tients with X5 > 0.15 kPa/(L/s) (p ¼ 0.0005 and p ¼ 0.04,
respectively) (Fig. 2b).
ROC analysis
When ROC analysis was performed with E/I LF data by deﬁning
asthma patients with FEV1,%predicted < 80% as positive for airway
narrowing, the area under the curve (AUC) was 0.789, with a
sensitivity of 0.86 and a speciﬁcity of 0.76 at a cut-off value of 0.42
(Fig. 3a). Similarly, when ROC analysis was performed with E/I LF
data by deﬁning patients with X5  0.15 kPa/(L/s) as positive for
airway narrowing, the AUC was 0.758, with a sensitivity of 0.67 and
a speciﬁcity of 0.75 at a cut-off value of 0.42 (Fig. 3b).
Fig. 2. Comparison of E/I LF values between bronchial asthma patients and healthy volunteers. a. Patients with FEV1,%predicted < 80% showed signiﬁcantly higher E/I LF levels than
healthy volunteers and patients with FEV1,%predicted  80%. b. Patients with X5  0.15 kPa/(L/s) exhibited signiﬁcantly higher E/I LF levels than healthy volunteers or patients with
X5 > 0.15 kPa/(L/s).
Fig. 3. Receiver operating characteristic (ROC) analysis. a. When ROC analysis was performed by deﬁning asthma patients with FEV1,%predicted < 80% as positive for airway narrowing,
the area under the curve was 0.789, with a sensitivity of 0.86 and a speciﬁcity of 0.76 at a cut-off value of 0.42. b. When ROC analysis was performed by deﬁning asthma patients
with X5 < 0.15 kPa/(L/s) as positive for airway narrowing, the area under the curve was 0.758, with a sensitivity of 0.67 and a speciﬁcity of 0.75 at a cut-off value of 0.42.
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E/I LF yielded a statistically signiﬁcant positive correlation with
R5 (r ¼ 0.34, p ¼ 0.017) and R20 (r ¼ 0.34, p ¼ 0.018) (Fig. 4a, b). E/I
LF also showed a signiﬁcant positive correlation with AX (r ¼ 0.40,
p ¼ 0.005) and Fres (r ¼ 0.32, p ¼ 0.024) (Fig. 4e, f). A negative
correlation was found between E/I LF and X5 (r ¼ 0.47,
p ¼ 0.0006) (Fig. 4d). However, no correlation was observed with
R5-R20 (Fig. 4c).Correlation between E/I LF and ﬂow-volume curves (Fig. 5aed)
E/I LF showed a negative correlation with FEV1/FVC (r ¼ 0.41,
p ¼ 0.003), FEV1,%predicted (r ¼ 0.44, p ¼ 0.002), _V50;%predicted
(r ¼ 0.49, p ¼ 0.0004), and _V25;%predicted (r ¼ 0.30, p ¼ 0.024).Correlation between E/I LF and log PC20 (Fig. 5e)
E/I LF was negatively correlated with log PC20 (r ¼ 0.30,
p ¼ 0.024).Multiple regression analysis to explain the _V50;%predicted with the
indices
_V50;%predicted was explained by E/I LF (p ¼ 0.018) and by X5
(p ¼ 0.048) independently by stepwise method.Multiple regression analysis of E/I LF (Table 2)
In the multiple regression analysis, log PC20 (p ¼ 0.048), X5
(p ¼ 0.021), and the smoking history (p ¼ 0.020) were identiﬁed as
factors affecting E/I LF level independently.Discussion
In this study, the E/I LF values were higher in bronchial asthma
patients with airway obstruction than healthy volunteers or asth-
matic patients with mild or no airway narrowing. In addition, E/I LF
showed a signiﬁcant correlationwith R5, R20, X5, AX, Fres, and ﬂow
volume. In these factors, E/I LF and X5 explained _V50 respectively
without confounding each other. X5, known as a parameter of
Fig. 4. Correlation between E/I LF and IOS factors.E/I LF showed a statistically signiﬁcant positive correlation with R5, R20, AX, and Fres (a, b, e, f), but did not with R5-R20 (c). E/I LF
showed a statistically signiﬁcant negative correlation with X5 (d).
Fig. 5. Correlation of E/I LF with respiratory function and log PC20. E/I LF showed a statistically signiﬁcant negative correlation with FEV1/FVC, FEV1,%predicted, _V50;%predicted,
_V25;%predicted, and log PC20.
T. Shimoda et al. / Allergology International 66 (2017) 132e138136peripheral capacitive reactance,8,9 log PC20, known as a parameter
of bronchial hyperresponsiveness, and smoking history were in-
dependent factors to explain the E/I LF. Based on the ROC analysis to
predict FEV1, an E/I LF of 0.42 is a cut-off value suggesting airway
narrowing.A correlation between R5 measured by IOS, and FEV1 has been
reported in bronchial asthma patients,16 but IOS is generally used as
a respiratory function indicator, independent of spirometry, pri-
marily for the evaluation of peripheral airways.17 IOS measure-
ments, in addition to spirometric determinations of % _V25 and %
Table 2
Multiple regression analysis to explain the _V50;%predicted with the indices.
Factor nek SST F p (Prob > F)
Sex 1 0.047 2.098 0.16
Age 1 0.0005 0.021 0.89
BMI 1 0.008 0.343 0.56
Atopic/non-atopic 1 0.0075 0.331 0.57
Smoking amount
Non/<10/>10 pack/y 2 0.192 4.237 0.022
X5 (kPa/(L/s)) 1 0.148 6.541 0.015
R5 (kPa/(L/s)) 1 0.004 0.173 0.68
PC20 1 0.189 8.348 0.006
The signiﬁcance of bold expresses p < 0.05.
T. Shimoda et al. / Allergology International 66 (2017) 132e138 137_V50, will not only enable further differentiation of peripheral airway
lesions but also serve as an index in monitoring the therapeutic
course.9,17,18
In asthmatic patients, the frequency and strength of lung sounds
are modiﬁed due to ﬂuctuations in respiratory ﬂow and airway
damage caused by inﬂammation.19,20 In broncho-provocation tests,
acute airway narrowing causes an increase in the frequency and
intensity of lung sounds while breathing at a constant ﬂow
rate.21e25 Habukawa et al. analyzed the strength ratio of high- and
low-frequency-range sounds at two points of the bronchi and the
chest wall.26 As a result, they reported that LSA was useful for
evaluating the impact of medications on bronchial asthma control.
Our previously proposed LSA, which uses E/I LF as an index of
inﬂammation and obstruction in asthmatic patients, is useful,
simple, and noninvasive.7
The IOS system is expensive and space-consuming, making it
impractical for use in general practice. In contrast, the recording of
lungsounds is anaffordable and space-savingoption.Weknowthat it
is still not clearwhether LSA could be bettermarker than spirometry.
The evaluations of the changes of various asthma-related indices
caused by the speciﬁc treatment may be useful study theme in the
future. Previous reports stressed the utility of LSAmainly in children,
who unable to perform reliable spirometry, however, we expect that
is useful for elder patients also.When sound analysis equipmentwill
beaffordable ingeneral practice, it couldbea sophisticated substitute
for stethoscope. This reportmaybeof somevalue as basic data for the
future. Even asthma is not severe, airwayobstructionmaybeuneven.
In this study, the LSAwas carried out by recording from just one area
(the base of the left lung). In our preliminary unpublished data, there
was no differences between the recording place is one area and
multiple area for the purpose so far. In this study, R5-R20, which is
supposed to be an indicator of the small airway obstruction, did not
related with E/I LF. The resistance at expiration could be meaningful
for evaluationof the small airways,7 but thebothofR5andR20values
were in average of the respiratory cycle.We are setting another study
for this issue.
In bronchial asthma patients, persistent airway inﬂammation
induces hyperresponsiveness and damage and triggers subsequent
structural changes (remodeling) of the airways, resulting in irre-
versible airﬂow restriction. Eosinophilic allergic airway inﬂamma-
tion is considered to be the main cause of most asthmatic cases,
while neutrophilic inﬂammation may play a role in some asthmatic
patients.27,28 Aging, smoking, obesity, and the presence of COPD
and chronic respiratory illnesses are known to affect airway nar-
rowing in bronchial asthma. Our multiple regression analysis
identiﬁed increased airway hyperresponsiveness, peripheral
airway lesions (seen as a decreased X5), and past smoking as factors
associated with an increase in E/I LF values. In bronchial asthma
patients, E/I LF seems to be increased by greater levels of airway
hyperresponsiveness and obstruction because of inﬂammation, as
well as by the peripheral airway obstruction seen with excessivesmoking. Because the lung sound is also caused by the air turbu-
lence, which may be affected by the airway wall deformations, for
example, the airway inﬂammatory roughness, remodeling bulge.
We know that the IOS evaluation is still controversial, therefore,
it is quite difﬁcult to say E/I LF can show the airway obstruction
deﬁnitively only by the signiﬁcant relationship with X5. However,
E/I LF and X5 related with _V50 independently, that might suggest
that both could be good indices of peripheral airway obstruction.
The pathological differences between them should be clariﬁed in
further studies. In conclusion, E/I LF can be an indicator of relatively
peripheral airway obstruction in bronchial asthma patients.Acknowledgments
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